top of page

Neuralink's Second Human Trial Faces Major Setback Amid Safety Concerns



Neuralink, Elon Musk's brain-computer interface (BCI) company, is facing significant concerns after its second human trial was halted due to health issues in the test subject. This development has sparked a heated debate across the U.S. about the safety and ethical implications of implanting chips in the human brain. 


Critics highlight potential risks to privacy, liberty, and health, while proponents argue the technology’s potential to treat neurological diseases and enhance cognitive functions justifies these risks. Neuralink plans to address these issues and optimize procedures before resuming trials, aiming for an April restart. The controversy highlights the broader ethical and regulatory challenges of integrating BCI technology into society.





Comentários


bottom of page